ISPOR 13th Annual International Meeting
May 3-7, 2008 Toronto, ON, Canada
SUBMISSION TIMELINE:
October 8, 2007
Access to Online
Submission System		 January 10, 2008
Abstract Submission
Deadline		 February 29, 2008
Acceptance
Notification

CONTRIBUTED RESEARCH SUBMISSION INFORMATION
GENERAL INFORMATION
  • Research abstracts (except Methods & Concept abstracts) must be organized as follows: OBJECTIVES: METHODS: RESULTS: CONCLUSIONS:
  • Research on all diseases is considered. Study methods include, but are not limited to, conjoint analysis, large database analysis, quasi-experimental analysis, literature or record review, modeling, naturalistic (observational) studies, randomized clinical trials and surveys.
  • Research on all health care interventions is considered including drugs, behavioral modification, disease prevention, gene therapy, medical device, screening, diagnostic procedures, dietary, health education, radiation therapy, and surgical procedures.
  • Reviews or methods papers are also considered as research abstracts.

  • Any human experimentation must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clin Res.1992; 40: 653-660).
  • Accepted abstracts will be published AS SUBMITTED in Value in Health and distributed at the Annual Meeting. Changes to abstracts will not be accepted after the Submission Deadline; therefore, they should be carefully written and edited prior to submission.
  • Research that has been published or presented at any national or international congress prior to this congress is discouraged.
  • Research RESULTS must be included for an abstract to be considered for presentation.

TOPICS FOR CONTRIBUTED RESEARCH SUBMISSIONS

  

SUBMIT OR MODIFY A RESEARCH ABSTRACT

Research submissions on the following topics are considered:
  • Clinical Outcomes Studies (COS)
  • Cost Studies (CS)
  • Patient Reported Outcomes Studies (Quality of Life Preference, Utility Treatment Satisfaction or Adherency (PRO)
  • Health Care Use & Policy Studies (HP)
  • Methods and Concepts (MC)


We strongly urge you to compose your abstract initially in your favorite word processor. Check the spelling, and make sure that your abstract, excluding the title and the author information, contains no more than 300 words. You will be asked for an e-mail address or alternate contact information for all authors, and you will not be allowed to complete the abstract submission until you have provided that information. If you are ready, you may now....

If you would like to see or modify an abstract that you have already submitted, or if you need to resume or delete a submission, fill in the boxes below and push the button beneath them.
Abstract ID:         Password:

Criteria for Evaluation of Research Abstracts:
Note: For studies involving data collection or analysis, the abstract will be REJECTED if RESULTS are NOT included.
 

Quality of the Study Criteria for Research Study Abstracts:

1.

 Research design is appropriate and transparent.

2.

 Data sources are appropriate and transparent.

3.

 Data analyses are appropriate and transparent.

4.

 Results ARE INCLUDED and are transparent and comprehensible.

5.

 Conclusions are consistent with the results.
Methods and Concepts Abstract Criteria:

1.

 Approach to method and/or concept is apparent.

2.

 Approach represents an advancement or is innovative.

3.

 Practical implications/recommendations are provided.

4.

 Papers do NOT need to be organized:
OBJECTIVES: METHODS: RESULTS: CONCLUSIONS:
Quality of the Abstract Presentation Criteria:

1.

 Objectives/research questions are clearly stated and objectives are addressed.

2.

 Factual information is kept separate from interpretations or implications / unbiased presentation.

3.

 Implications/results, as presented, are easy to understand.

Abstract Review Process and Notification of Authors:

  • All research abstracts will be peer reviewed by at least 3-blinded reviewers.
  • Research abstracts will be evaluated based on the items listed under Criteria for Evaluation of Research Abstracts.
  • All presenters will be notified by email by February 29, 2008

Presentation of Research Abstracts:
PODIUM PRESENTATIONS

  • All oral presentations will be programmed into 15-minute time slots. You will have 12 minutes for presentation and 3 minutes for questions and discussion. It is important that you not exceed 15 minutes. Financial support for the research must be presented at the beginning of the presentation.
  • Audio/visual equipment: An LCD projector and laptop computer will be provided. Slide projection or overhead transparency projection are not allowed.
  • Presenter MUST email electronic slides NOT LESS THAN 10 DAYS in advance of the Congress/Meeting to the ISPOR office at podium@ispor.org

POSTER PRESENTATIONS

  • At least one author must be present during the Author Discussion Hour given below.
  • Poster Presentation Timetable:
Monday, May 5, 9:00-8:00 and Tuesday, May 6, 9:00-7:00
  • The abstract title and authors must be placed at the top of the board, and the lettering must be at least 1 inch high. A copy of the abstract, typed in large print, must be placed in the upper left hand corner of the board. Subtitles should correspond to those used in your abstract submission. Illustrations, charts, tables, lettering, and drawings must be readable from distances of at least three feet. Financial support must be displayed at the lower right hand corner of the board.
  • Mounting materials will be available on-site.

Abstract Submission Checklist

 Have you titled your abstract?
Have you submitted your abstract as research, workshop or as an issue panel?
Are you a student or new investigator?
Do you have a preference for podium only or poster only?
Has your abstract been presented at a prior meeting?
Have you indicated the name and address of the institution that has provided you with financial support?
Have you and your co-authors conformed to all the 2008 abstract policies and procedures?
Will you be submitting your presentation for inclusion in the ISPOR Research Digest?
Do you certify that you have the right to publish this abstract and thereby indemnify ISPOR from any claims arising from this material?

TOPIC SUBCATEGORIES ARE LISTED BELOW TO AID IN YOUR SELECTION:
 
CLINICAL OUTCOMES STUDIES (COS)
Efficacy/Effectiveness (EE)
Co-morbidities (CMB)
Adverse Events (SE)
Diagnosis (D)
Survival (S)
Risk Factors (RF)
Prevalence (PV)		  
COST STUDIES (CS)
Budget Impact (BI)
Cost-Benefit Analysis (CB)
Cost-Effectiveness Analysis (CE)
Cost-Efficiency Analysis (CEE)
Cost-consequence (CN)
Cost-Minimization Analysis (CM) 		Cost-Utility Analysis (CU)
Cost of Illness (CoI)
Cost of Treatment (CoT)
Cost Comparison (CC)
Productivity/Indirect Costs (PI)
Resource Use (RU)
PATIENT REPORTED OUTCOMES STUDIES (PRO)
Adherence/Compliance (AD)
Quality-of-Life (QoL)
Health States/Utilities (hrQol)
Patient Reported Outcomes (PRO)
Work Performance/Productivity (WP)		 Willingness-to-Pay (WTP)
Patient Preference (PP)
Patient Satisfaction (PS)
Treatment Satisfaction (TS)
Instrument Validation (IV)
HEALTH CARE USE & POLICY STUDIES (HP)
Consumer Role in Health Care (CRH)
Diagnosis Related Group (DRG)
Disease Management (DISM)
Drug or Devices & Health Policy (DHP)
Drug Use (DU)
Equity and Access (EA)
Formulary Development (FD)
Health Care Reimbursement (HR)
Health Care Expenditure (HE)
Health Care Management including pharmaceutical care (HM)		 Health Care Information (HI)
Medical Devices/Diagnostics (MD) Patient / Provider / Payer / Researcher Education (PE)
Patient Registries (PR)
Pharmacogenomics (PG)
Post Marketing Studies (PMS)
Prescribing Behavior (PB)
Quality of Care including Quality Improvement (QC)
Regulation of Health Care Sector (RHS)
Treatment Patterns / Guidelines (TPG)
METHODS AND CONCEPTS (MC)
- Clinical Outcomes Studies (CO)
- Costs Studies including CE/CB/CU, resources use, and productivity (CS)
- Database Studies & Management (DM) 		- Study & Methods Design-General (SD)
- Modeling Studies (MS)
- Patient Registry (PR)
Quality of Life / PRO / Utility / Preference Studies (QOL)

Disease/Disorder for Research Submissions:

When submitting your abstract, you must select the DISEASE/ DISORDER that best describes your research. If no disease or multiple diseases apply to your abstract, select Multiple Diseases/No Specific Disease. If the disease is not listed, select Other.
 

- Allergy
- Auto-immune Disorders
- Arthritis-Osteoarthritis
- Arthritis-Rheumatoid Arthritis
- Arthritis-Other
- Asthma
- Cancer
- Cardiovascular Disease-Angina /Ischemia
- Cardiovascular Disease-Angioplasty
- Cardiovascular Disease-Arrhythmia
- Cardiovascular Disease-Atrial Fibrillation
- Cardiovascular Disease-Congestive Heart Failure / Heart Failure
- Cardiovascular Disease-Coronary Artery Disease
- Cardiovascular Disease-Hypercholesterolemia
- Cardiovascular Disease-Hypertension
- Cardiovascular Disease-Left Ventricular Dysfunction (LVD)
- Cardiovascular Disease-Myocardial Infarction
- Cardiovascular Disease-Peripheral Arterial Disease
- Cardiovascular Disease-Thrombosis including DVT
- Cardiovascular Disease-Multiple disorders
- Cardiovascular Disease-Other
- Diabetes
- Endocrine Disorders-other (Pituitary Gland/Thyroid)
- Eye
- Ear
- GI Disorders (including Dyspepsia, GERD, Irritable Bowel, Liver, Ulcers)
- Health, Women’s
- Health, Men’s
- Health, Children’s
- Health, Elderly
- Hematological Disorders
- Infection (including leg ulcers & bronchitis)
- Infection-HIV
 - Mental Health-Alcoholism / Drug Abuse
- Mental Health-Anxiety
- Mental Health-Attention Deficit Disorder
- Mental Health-Bi-Polar Disorder
- Mental Health-Depression
- Mental Health-Dementia
- Mental Health-Obsessive Compulsive Disorder
- Mental Health-Psychosis
- Mental Health-Schizophrenia
- Mental Health-Other
- Metabolic Disorders
- Muscular-skeletal Disorders including Carpal Tunnel Syndrome
- Neurological Disorders-Alzheimer’s Disease
- Neurological Disorders-Epilepsy
- Neurological Disorders-Cystic Fibrosis
- Neurological Disorders-Migraine
- Neurological Disorders-Multiple Sclerosis
- Neurological Disorders-Parkinson’s Disease
- Neurological Disorders-Restless Leg Syndrome
- Neurological Disorders-Other
- Obesity
- Osteoporosis
- Pain
- Respiratory Disorders (including Chronic Obstructive Pulmonary Disease [COPD])
- Skin
- Smoking
- Stroke
-Urinary/Kidney (including Renal Disease, Irritable Bladder Syndrome)
- Surgery
-Veterinary Medicine - Multiple Diseases/No Specific Disease
ISPOR 13th Annual International Meeting